These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 11789362

  • 1. [Effect of thiazide therapy in the prophylaxis of calcium lithiasis].
    Fernández Rodríguez A, Arrabal Martín M, García Ruiz MJ, De Haro Muñoz T, Zuluaga Gómez A.
    Arch Esp Urol; 2001 Nov; 54(9):1047-54. PubMed ID: 11789362
    [Abstract] [Full Text] [Related]

  • 2. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [Abstract] [Full Text] [Related]

  • 3. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y, Nonomura M, Takeuchi H, Kawamura J, Yoshida O.
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [Abstract] [Full Text] [Related]

  • 4. [Comparative variations in natriuresis and urinary calcium in patients with hypercalciuric lithiasis treated with thiazide diuretics].
    Jungers P, Lacour B, Daniel J, Chauveau P, Bruneau M, Bailly M.
    Nephrologie; 1984 Sep; 5(5):202-4. PubMed ID: 6531057
    [Abstract] [Full Text] [Related]

  • 5. [Thiazide diuretics and calcium metabolism: role in renal lithiasis and osteoporosis].
    Suárez Fernández C, Ruilope Urioste LM.
    An Med Interna; 1996 Aug; 13(8):401-6. PubMed ID: 8983370
    [Abstract] [Full Text] [Related]

  • 6. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L, Meschi T, Guerra A, Novarini A.
    J Cardiovasc Pharmacol; 1993 Aug; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [Abstract] [Full Text] [Related]

  • 7. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY, Peterson R, Sakhaee K, Fuller C, Preminger G, Reisch J.
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [Abstract] [Full Text] [Related]

  • 8. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M, Yendt ER.
    Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033
    [Abstract] [Full Text] [Related]

  • 9. The effect of thiazide diuretics on carbohydrate-induced calciuria in patients with recurrent renal calculi.
    Wilson DR, Siddiqui AA, Ehrig U.
    J Lab Clin Med; 1975 Jul; 86(1):118-25. PubMed ID: 239075
    [Abstract] [Full Text] [Related]

  • 10. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides.
    Hering F, Lutzeyer W.
    Eur Urol; 1979 Jul; 5(1):29-31. PubMed ID: 428408
    [Abstract] [Full Text] [Related]

  • 11. Effect of thiazides on the hypercalciuria of phosphate depletion.
    Meyer-Sabellek W, Brautbar N, Moser S, Montcalm A, Massry SG.
    J Lab Clin Med; 1980 Nov; 96(5):830-7. PubMed ID: 7419966
    [Abstract] [Full Text] [Related]

  • 12. [Effect of potassium citrate in the prophylaxis of urinary lithiasis].
    Jiménez Verdejo A, Arrabal Martín M, Miján Ortiz JL, Hita Rosino E, Palao Yago F, Zuluaga Gómez A.
    Arch Esp Urol; 2001 Nov; 54(9):1036-46. PubMed ID: 11789361
    [Abstract] [Full Text] [Related]

  • 13. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ, Peterson R, Pak CY.
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [Abstract] [Full Text] [Related]

  • 14. Prevention of recurrent nephrolithiasis.
    Goldfarb DS, Coe FL.
    Am Fam Physician; 1999 Nov 15; 60(8):2269-76. PubMed ID: 10593318
    [Abstract] [Full Text] [Related]

  • 15. [Changes in the urine composition induced by indapamide in subjects with recurrent calcic calculosis: a possible alternative to thiazide diuretics].
    Elia GF, Borghi L, Barbarese F, Melloni E, Amato F, Trapassi MR, Quarantelli R, Giannini A, Novarini A.
    Ann Ital Med Int; 1987 Nov 15; 2(2):94-9. PubMed ID: 3275280
    [No Abstract] [Full Text] [Related]

  • 16. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.
    Pearle MS, Roehrborn CG, Pak CY.
    J Endourol; 1999 Nov 15; 13(9):679-85. PubMed ID: 10608521
    [Abstract] [Full Text] [Related]

  • 17. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice.
    Mardis HK, Parks JH, Muller G, Ganzel K, Coe FL.
    J Urol; 2004 Jan 15; 171(1):85-8. PubMed ID: 14665850
    [Abstract] [Full Text] [Related]

  • 18. [Diuretics and osteoporosis].
    Rejnmark L, Mosekilde L, Andreasen F.
    Nord Med; 1998 Feb 15; 113(2):53-9. PubMed ID: 9497618
    [Abstract] [Full Text] [Related]

  • 19. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
    Arrabal-Polo MA, Arias-Santiago S, de Haro-Muñoz T, Lopez-Ruiz A, Orgaz-Molina J, Gonzalez-Torres S, Zuluaga-Gomez A, Arrabal-Martin M.
    Urology; 2013 Apr 15; 81(4):731-7. PubMed ID: 23375914
    [Abstract] [Full Text] [Related]

  • 20. Medical treatment to prevent recurrent calcium urolithiasis. A guide to critical appraisal.
    Churchill DN.
    Miner Electrolyte Metab; 1987 Apr 15; 13(4):294-304. PubMed ID: 3627054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.